{
    "2018-06-29": [
        [
            {
                "time": "",
                "original_text": "医药生物行业2018年中期投资策略：给确定性溢价 增长为王",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "确定性溢价",
                        "增长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：回调不改长期逻辑 把握业绩确定性",
                "features": {
                    "keywords": [
                        "医药",
                        "周报",
                        "回调",
                        "长期逻辑",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}